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KEY MESSAGE
Testicular tissue cryopreservation is offered to prepubertal boys whose fertility is at stake. If the tissues present
a risk of contamination, e.g systemic cancers, testicular cell suspensions must be generated and cryopreserved.
As human prepubertal tissue is scarce, prepubertal mouse testes were used to find an optimal cryopreservation
protocol.
A B S T R A C T
Research question: From a clinical perspective, which parameters grant optimal cryopreservation of mouse testicular cell suspensions?
Design: We studied the effect of different cryopreservation rates, the addition of sugars, different vessels and the addition of an apoptotic inhibitor on
the efficiency of testicular cell suspension cryopreservation. After thawing and warming, testicular cell suspensions were transplanted to recipient
mice for further functional assay. After selecting the optimal cryopreservation procedure, a second experiment compared the transplantation effi-
ciency between the selected freezing protocol and fresh testicular cell suspensions.
Results: Multiple- and single-step freezing did not differ significantly in terms of recovered viable cells (RVC) (33 ± 28% and 38 ± 25%). The addition of
sucrose did not result in a higher RVC (33 ± 20%). Cells frozen in vials recovered better than those frozen in straws (52 ± 20% versus 33 ± 20%;
P = 0.0049). The inclusion of an apoptosis inhibitor (z-VAD[Oe]-FMK) significantly increased the RVC after thawing (61 ± 18% versus 50 ± 17%; P = 0.0480).
When comparing the optimal cryopreservation procedure with fresh testicular cell suspensions, a lower RVC (63 ± 11% versus 92 ± 4%; P < 0.0001)
and number of donor-derived spermatogonial stem cell colonies per testis (34.04 ± 2.34 versus 16.78 ± 7.76; P = 0.0051) were observed.
Conclusion: Upon freeze–thawing or vitrification–warming, and assessment of donor-derived spermatogenesis after transplantation, Dulbecco’s modified
Eagle’s medium supplemented with 1.5M dimethyl-sulphoxide, 10% fetal calf serum and 60 µM of Z-VAD-(OMe)-FMK in vials at a freezing rate of
−1°C/min was optimal.
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Introduction
Gonadotoxic therapy, such as chemotherapy and radiation, might result
in subfertility, leading to the need for fertility-preservation tech-
niques (Hudson, 2010; Jahnukainen et al., 2015). In women wishing
to undergo fertility preservation, ovarian tissue preservation com-
bined with transplantation of ovarian cortex fragments has been
successful, and has led to live births (Demeestere et al., 2015). For
men and adolescent boys, sperm banking is the gold standard for fer-
tility preservation. Prepubertal boys who cannot yet produce sperm
do not have this option (Hudson, 2010; Tournaye et al., 2014), al-
though they do have spermatogonial stem cells (SSCs). This opens
up the possibility of cryopreserving testicular tissue containing
SSCs to safeguard their chances of having their fertility restored in
the future.
Effective protocols to cryopreserve human testicular tissue exist
(Baert et al., 2013; Keros et al., 2005), and several fertility centres
worldwide already offer testicular tissue cryopreservation to pa-
tients before fertility-compromising therapy. Testicular tissue
cryopreservation and grafting is the most efficient strategy to pre-
serve and restore fertility in animal models (Van Saen et al., 2009).
In cases of systemic cancers, however, autologous grafting repre-
sents a high risk of reintroducing cancer cells in the patient
(Jahnukainen et al., 2001). As such, standard testicular tissue
cryopreservation could be carried out in view of subsequent genera-
tion of testicular cell suspensions (TCSs) from which cancerous cells
could be depleted, while SSCs would be propagated in vitro for sper-
matogonial stem-cell transplantation (SSCT) (Giudice et al., 2017;
Goossens et al., 2013). In future clinical application, cryopreservation
of in-vitro propagated TCS is required during safety testing before
SSCT (Figure 1).
Currently, the highest post-thawing–warming viability of human
TCSs was obtained after vitrification (55 ± 24%). The recovery rate of
viable SSCs is unknown as no functional proof was provided (Sá et al.,
2012), highlighting the need for an effective procedure for SSC
preservation.
In the present study, we conducted a thorough screening of dif-
ferent cryopreservation methods with the aim of designing an efficient,
reproducible and clinically friendly cryopreservation protocol for TCSs
containing SSCs. Our primary goal was to increase the number of viable
SSCs after thawing–warming as it is vital to the success of SSCT. As
human prepubertal tissue is scarce, prepubertal mouse TCSs were
used.
Materials and methods
Experimental design
The present study was conducted in two parts. The experimental design
(Part 1 and Part 2) is presented in Figure 2A and Figure 2C.
Animals and testicular cell isolation
Approval for this study was given by the Animal Care and Use Com-
mittee of the Vrije Universiteit Brussel on 14 October 2013 (approval
number 13-216-1), and on 27 February 2017 (approval number 14-
216-3). Recipient and donor mice were obtained by crossing male
inbred C57BL with female inbred SV129 green fluorescence protein
(GFP). Male GFP negative (GFP-) F1-hybrids were used as recipients,
whereas neonatal (aged 6–10 days) GFP-positive (GFP+) F1-hybrid pups
were used as donors. Each replicate consisted of one single donor
testis taken from one mouse and 12 replicates were considered per
condition. Donor testicular cells were isolated as previously described
(Ogawa et al., 1997) with minor modifications. Briefly, after weigh-
ing, testicular tissue was incubated in Dulbecco’s modified Eagle’s
medium (DMEM)/F12 containing 1 mg/ml collagenase IV (C5138;
Sigma-Aldrich, Diegem, Belgium) and 30 mg/ml desoxyribonuclease
(DNAse; DN25; Sigma-Aldrich) for 20 min in a 37°C shaking water bath.
After incubation, the testicular tubules were washed twice with 10 ml
of DMEM/F12 by centrifugation for 5 min at 600 g. Subsequently, 10 ml
DMEM/F12 solution supplemented with 0.25% trypsin (T4665; Sigma-
Aldrich) and 1 mM ethylenediaminetetracetic acid (E6511; Sigma-
Aldrich) was added to the cell pellet and incubated in a 37°C shaking
water bath for 5 min. The trypsin reaction was halted by adding 4%
fetal calf serum (FCS) (10500-056; Life Technologies) and 30 mg/ml
DNAse. The solution was filtered through a 40 µm nylon mesh cell
strainer (35234; BD Falcon, Leuven, Belgium), centrifuged for 5 min
at 600 g and the supernatant removed.
Testicular tissue biopsy 
from a 
patient requiring 
gonadotoxic treatment
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Figure 1 – Strategy to preserve fertility in prepubertal cancer patients. For restoring fertility, the biopsy will be enzymatically digested.
Spermatogonial stem cell (SSC) numbers will be increased during propagation in vitro for later autotransplantation. To safeguard the
success of fertility restoration, cultured testicular cells must be successfully cryopreserved during the lag-time of safety screening.
SSCT, spermatogonial stem-cell transplantation.
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Cryopreservation and thawing–warming
After isolation, testicular cells were suspended in 10 µl injection
medium (DMEM/F12, 10% penicillin streptomycin [15140-122; Life
Technologies]) per mg of testicular tissue resulting in TCS with a con-
centration of 1–2 x 106 cells/ml.
On the basis of the cryopreservation protocol developed by
Frederickx et al. (2004), further modifications were tested (Figure 2B).
The first experimental group focused on the influence of differ-
ent freezing rates. Testicular cell suspensions were cryopreserved
in 200 µl cryopreservation medium as described by Frederickx et al.
(2004) (DMEM/F12 supplemented with 1.5M dimethyl sulfoxide [DMSO]
and 10% FCS) with a multiple-rate controlled slow freezing pro-
gramme (MSF) or a controlled slow freezing rate programme (SSF)
using a biofreezer (DB1 Freezer; Biotronics Ltd, Rotselaar, Belgium)
to cool cells stored in 0.5 ml CBS cryostraws (14650; Fertipro NV,
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Experiment 5: -AI versus +AI
Experiment 2: -S versus +S
B
SSF
-S
vials
-T
+AI
Optimized protocol Fresh testicular cells
Number of testes 
presenting donor-derived 
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Figure 2 – Experimental design. For each experimental replicate, cell isolation, freezing–thawing or vitrification–warming and
transplantation of cells was carried out. After freezing–thawing or vitrification–warming, the percentage recovery of viable cells (%RVC)
was reported and the testicular cell suspensions were transplanted (SSCT) to recipient mice. After 12 weeks, transplanted testes were
collected and the tubular fertility index (TFI) was analysed (A). The optimization of the cryopreservation protocol was performed step-wise,
it included five independent experiments. Experiment 1 compared a multiple (MSF) and single (SSF) controlled-slow freezing protocols
and vitrification (VF). A second experiment evaluated the influence of a non-permeating cryoprotective agent, sucrose (S). A third
experiment compared two types of cryopreservation vessels (straws versus vials). The fourth experiment considered the addition of a high
molecular weight cryoprotective agent, trehalose (T) and the fifth experiment investigated the addition of an apoptotic inhibitor (AI),
z-VAD(Oe)-FMK (B). In a second set of experiments the optimized cryopreservation protocol was compared with fresh testicular cell
suspensions (C). Description of the relevant experimental conditions for each cryopreservation protocol used in the present study (D). FCS,
fetal calf serum; GFP, green fluorescence protein. SSC, spermatogonial stem cell.
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Beernem, Belgium). Vitrification was achieved by exposing 200 µl of
the TCS to 200 µl of a DMEM/F12 based vitrification solution, includ-
ing 0.75M DMSO and 0.67 M ethylene glycol for 10 min, followed by
a 5-min wash by centrifugation at 600 g and resuspension in 100 µl
of injection medium. Cells were then incubated in 200 µl of a second
vitrification solution with a final concentration of 1.05 M DMSO, 1.35 M
ethylene glycol, 250 mM sucrose and 10% FCS for 5 min. A total of
200 µl/straw were loaded into cryostraws and subsequently plunged
into LN2 (Lee et al., 2014; Rodrigues et al., 2008).
In the second group of experiments, the influence of a non-
permeant cryoprotective agent (CPA) was evaluated by adding 70 mM
of sucrose to the original cryopreservation medium. Cells were frozen
by means of a biofreezer with a controlled slow freezing rate of −1°C/
min until −40°C (Pan et al., 2017). In the third group, the influence
of the type of cryopreservation vessel was investigated (cryovials versus
cryostraws). The TCSs were cryopreserved as described by Frederickx
et al. (2004) using 1.8 ml vials (NUNC377267; VWR, Leuven, Belgium).
An isopropyl alcohol container (479–3200; Mr Frosty Freezing Con-
tainer; VWR) was used for cooling and cells cooled in a −80°C freezer
overnight. These containers provide a slow freezing rate of about −1°C/
min. In the fourth group, the influence of the high molecular weight
sugar trehalose (T9531, Sigma-Aldrich, Diegem, Belgium) was studied
by adding 200 mM to the original cryopreservation medium (Buchanan
et al., 2004; Lee et al., 2013a). Vials were used to freeze the TCS using
an isopropyl alcohol container (−1°C/min), which was put in a −80°C
freezer overnight. In the final set of experiments, 60 µM of Z-VAD(OMe)-
FMK (ab120487; Abcam, Cambridge, UK) was included in the original
cryoprotective medium to study the effect of an apoptosis inhibitor
(Ha et al., 2016). An isopropyl alcohol container (−1°C/min) was used
to freeze the TCSs overnight in a −80°C freezer.
All experimental groups were carried out step-wise and based on
the results of the previous experiment. For each condition, every
cryostraw or cryovial was loaded with 200 µl of the cell suspension
containing 1–2x106 cells/ml. The cryomedium was added drop-wise
to the cell suspension in a 1:1 (v/v) ratio leading to the above final
concentrations. For all procedures, pre-cooled (in ice water)
cryopreservation medium was used. After cooling, cryostraws or
cryovials were stored in LN2 for a period ranging from 2 weeks to 3
months. Thawing–warming was carried out in a 37°C water bath for
30 s according to Frederickx et al. (2004). Protocol details are shown
in Figure 2D.
Cell counting and viability assessment
Concentration and viability were assessed with a Tali® image-based
cytometer (T10796; Life Technologies, Ghent, Belgium) at three time
points: immediately after cell isolation, after the addition of CPA, and
subsequent to the freeze–thawing or vitrification–warming proce-
dure. A total of 10 µl of the cell suspension were diluted by a factor
of 10 with injection medium. One microliter of the Tali® Dead cell red-
viability kit (A10786; Life Technologies) was added. After a 5-min
incubation in the dark, 25 µl of this solution was loaded onto a Tali®
slide (T10794; Life Technologies).
After thawing–warming, the percentage recovered viable cells (RVC)
was calculated as follows:
%
.
.
RVC = No of viable cells after thawing or warming
No of viable cells after isolation
×100
Transplantation experiments
Six to eight weeks before the transplantation procedure, endog-
enous spermatogenesis in recipient mice was suppressed by treatment
with busulfan (40 mg/kg). Before SSCT, mice were anesthetized with
150 µl of a mixture of 0.1 mg/ml Medetor (Pfizer Animal Health NV,
Louvain-La-Neuve, Belgium) and 0.75 mg/ml ketamine (Santé Animale,
Libourne, France), dissolved in saline solution. After disinfection of
D
Protocol Permeable CPA
Non-permeable 
CPA
Vessel Cryopreservation rate
MSF 1.5M DMSO 10% FCS Straws
5°C/min until 7°C,
equilibration 15 
min,
0.3°C/min until 40°C
SSF 1.5M DMSO 10% FCS Straws
1°C/min until 
40°C
VF
0.75M DMSO + 
0.67M EG / 
1.05M DMSO + 
1.35M EG
250 mM sucrose + 
10% FCS
Straws
plunged into LN2
(vitrification)
+S 1.5M DMSO
70 mM sucrose + 
10% FCS
Straws
1°C/min until          
40°C
vials 1.5M DMSO 10% FCS Vials
1°C/min until 
80°C
+T 1.5M DMSO
200 mM trehalose 
+ 10% FCS
Vials
1°C/min until 
80°C
+AI 1.5M DMSO
60 µM Z-
VAD(OMe)-FMK + 
10% FCS
Vials
1°C/min until 
80°C
Fig. 2 – (continued)
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the incision area with cedium chlorhexidini alcoholicus 0.5% (BE351513;
Laboratoires Gifrer Barbezat, France), the abdomen was opened and
the testes were exteriorized. After thawing, cells were washed, as-
sessed for concentration and viability, then resuspended in injection
medium and 0.5 ml FCS (FCS; 10500-056; Life Technologies)] to obtain
a concentration of 10–20 x 106 cells/ml. The goal was to inject 2 x 105
cells (10 µl) of the TCS. Transplantations were carried out under a
stereomicroscope as previously described (Frederickx et al., 2004).
Briefly, the efferent duct was immobilized and the microinjection
pipette introduced through the efferent duct until the tip reached the
rete testis. Trypan blue dye was added to the tip of the pipette to vi-
sualize the entry of the injected solution in the seminiferous tubules.
Immediately after transplantation, mice were injected with a 100 µl
of an antibiotic solution [1900 µl physiological saline serum contain-
ing 100 µl of Baytril 2.5 % (Bayer, Diegem, Belgium)].
Immunohistochemistry and histological analysis
Twelve weeks after transplantation, recipient males were killed by
cervical dislocation. The testes were collected, decapsulated, fixed
in acetic-formol-alcohol (PFAFA0060AF59001; Labonord, Rekkem,
Belgium) and embedded in paraffin. From each testis, 5-µm thick serial
sections were cut with a microtome (SM2010R; Leica, Brussels,
Belgium). Slides were deparafinized in xylene and rehydrated in a de-
scending series of isopropanol (100%, 100%, 90% and 70%) followed
by a 5-min wash in phosphate buffered saline (PBS) (70011051; Life
Technologies). Endogenous peroxidases were blocked in 0.3% hy-
drogen peroxide (H3410-500 ml; Sigma-Aldrich) for 30 min, after which
the sections were incubated with 3% normal goat serum (039B304;
tebu-bio, Boechout, Belgium) for 30 min. Then, the slides were in-
cubated overnight with the primary mouse anti-GFP antibody (1/
200; sc-9996; tebu-bio) at 4°C. The next morning, the sections were
washed three times with PBS for 5 min followed by incubation with
a rabbit anti-mouse secondary antibody (K5007; Dako, Heverlee,
Belgium) for 1 h at room temperature. After three washes with PBS,
3,3’-diaminobenzidine (1/50; K5007; Dako) was added to visualize the
immunoreactivity. All slides were counterstained with haematoxylin.
The sections were dehydrated in a mounting series of alcohol (70%,
90%, 100% and 100%) and in xylene. Finally, slides were mounted using
acrytol mounting medium (100406; Surgipath, Labonord) and analysed
under an Olympus IX 81 inverted bright field microscope (IX81S1F-
3, Aartselaar, Belgium). Adult GFP+ mouse testicular tissue sections,
with and without the addition of primary mouse anti-GFP antibody were
used as positive and negative controls, respectively. Thirty serial cross-
sections per testis (with a 100 µm shift between each slide) were blindly
analysed to assess the tubular fertility index (TFI), which is the per-
centage of tubules containing donor-derived spermatogenesis
(Paniagua and Nistal, 1984) (Figure 3B–3E).
Whole-mount testes assay
After isolation and decapsulation, testicular tubules were fixed in 4%
paraformaldehyde (PFA) (47608; Sigma-Aldrich, Machelen, Belgium)
for 2 h at 4°C and washed in PBS. Tubules were incubated in 1 M
glycine (CAS56-40-6; Calbiochem, Leuven, Belgium) for 30 min at room
temperature. After incubation, tubules were mounted and spread onto
a slide with SlowFade® Gold antifade reagent (S36939, Life Tech-
nologies) according to Gassei et al. (2015), and analysed in the GFP
channel of a fluorescence microscope (Gassei et al., 2015). Donor-
derived colonies were visualized by GFP auto-fluorescence using a
fluorescence microscope (Nikon Eclipse Ti-S, Nikon, city, Belgium)
and a confocal microscope (Leica Microsystems, Inc., Buffalo Grove,
IL, USA) to verify its characteristics. The number and length of colo-
nies was measured by computer-assisted morphometry software
(Image J, NIH). Donor-derived colony counts were obtained from
manual counts from magnified digital images based on the obser-
vation that colonies have distinctive, tapered, lightly stained areas at
their edges where cells are still spreading horizontally along the semi-
niferous tubules and vertical differentiation is incomplete
(Figure 4D–4F) (Dobrinski et al., 1999). The number of colonies per
testis was defined as the total number of genuine, lightly staining
colony edges present in each sample. Green fluorescent segments
smaller than 0.1 mm in length were excluded as these do not comply
with the definition of a colony (Dobrinski et al., 1999; Nagano et al.,
1999).
Statistics
GraphPad Prism, version 5.0 (GraphPad Software, Inc., La Jolla, CA,
USA), was used for data presentation and statistical analyses. All data
are presented as means ± SD. Data were tested for normality using
the Shapiro–Wilk test, and the statistical differences between the dif-
ferent cryopreservation protocols evaluated with the non-parametric
Kruskal–Wallis test (Dunn’s post-hoc) for %RVC, t-test for donor-
derived colony activity and chi-squared for the number of testis
presenting donor-derived spermatogenesis. P < 0.05 was consid-
ered significant.
Results
Part 1
Recovery of viable testicular cells after cryopreservation and
thawing–warming
Cryopreservation and thawing–warming of cells generally results in
cell loss caused by cryopreservation-induced cell damage. To improve
the recovery of TCSs, we investigated various cryopreservation con-
ditions and compared the percentage of recovered RVC before and
after cryopreservation and thawing–warming. Absolute numbers of
RVC before and after freezing–thawing or vitrification–warming
are shown in Table 1. The percentage RVC obtained after each
cryopreservation protocol is presented in Figure 3A.
Influence of freezing rates. After freezing–thawing, no significant
differences were observed when comparing multiple (MSF 1.2 x 105
± 1.1 x 105 RVC; 33 ± 28%) with single-step freezing programmes (SSF
1.7 x 105 ± 1.3 x 105 RVC; 38 ± 25%). In contrast, vitrification resulted
in a significantly lower RVC (3.3 x 104 ± 3.8 x 104; 10 ± 14%; P < 0.0001)
compared with the other protocols. For further optimization, SSF was
chosen as this protocol was more time– and cost-efficient com-
pared with MSF.
Influence of adding a non-permeable cryoprotective agent. Addition
of 70 mM sucrose (+S) to the cryopreservation medium resulted in
an immediate decrease in the number of viable cells (3.3 x 105 ± 1.8
x 105; P = 0.0047) compared with freshly isolated cells. After freezing–
thawing, RVC was 33 ± 20% (1.2 x 105 ± 8.0 x 104). As the addition of
sucrose did not improve the cryopreservation outcome, further
cryopreservation procedures were carried out without sucrose.
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Influence of the cryopreservation vessel. Cells frozen in vials re-
covered significantly better than those frozen in straws, 1.0 x 105 ±
5.0 x 104 (33 ± 20%) cells were recovered when freezing in straws
whereas 2.0 x 106 ± 1.2 x 105 (65 ± 16%) cells were recovered when
frozen in vials with an RVC of 52 ± 20% (P = 0.0049). Consequently,
the subsequent trials were performed using vials.
Influence of adding a high molecular-weight non-permeable cryo-
protective agent. The addition of trehalose did not influence
cell recovery. A 37 ± 23% RVC was achieved. Consequently, the
following procedures were carried out using medium without
trehalose.
Influence of adding a broad-spectrum anti-apoptotic factor. The
addition of Z-VAD-(OMe)-FMK to the cryopreservation medium en-
hanced cell viability and RVC. After freezing and thawing, a significant
(P = 0.0480) improvement in the number of viable cells (2.6 x 105 ±
8.5 x 104 versus 2.3x105 ± 9.2x104) was achieved, yielding a RVC of 61
± 18% versus 50 ± 17%, with and without Z-VAD-(OMe)-FMK,
respectively.
Spermatogonial stem cell transplantation assay
To evaluate the presence and direct effects of cryopreservation on
the SSC population, TCSs were transplanted into germ-cell de-
pleted recipient mice before and after the freeze–thaw and vitrification–
warming cycle for each experimental condition. The TFI was then
determined by the percentage of GFP+ tubules (Figure 3B–3E). In line
with an increase in cell viability, we found the highest TFI 12 weeks
after transplantation for cryopreservation experiments, including vials
and the apoptotic inhibitor (9% and 7%, respectively). The percent-
age of TFI did not increase in the other conditions. The average number
of transplanted cells and TFI are presented in Table 2.
Part 2
In part two, the optimal cryopreservation protocol from part one
(1.5 M DMSO, 10% fetal calf serum and 60 µM of Z-VAD-[OMe]-FMK
in vials at a freezing rate of −1°C/min] was compared with fresh
TCSs. The number of SSCs and their colonizing activity was as-
sessed by the number and length of SSC colonies after transplantation
(Figure 4). After digestion of testicular tissues, fresh TCSs pre-
sented a RCV of 92 ± 4%, whereas cryopreservation of TCSs using
1.5M DMSO + 10% FCS + Z-VAD-(OMe)-FMK in vials resulted in
63 ± 11% RVC after thawing, showing no difference with the RVC
achieved in Part 1.
The number of testes with donor derived spermatogenesis
after SSCT was the same in both fresh and cryopreserved TCSs. A
significant difference (P = 0.0051) was found in the numbers of SSC
colonies per testes (34.04 ± 2.34 versus 16.78 ± 7.76 for fresh and
cryopreserved TCSs, respectively), indicating a loss of 51% of initial
SSCs as a result of the freezing procedure. No differences were
found in the length of the surviving colonies (3.94 ± 2.47 versus
2.95 ± 0.37 mm for TCSs before and after freeze–thawing, respec-
tively) (Table 3).
Figure 3 – Stepwise optimization of the cryopreservation protocol included the comparisons of different freezing rates (Experiment 1),
sugars (Experiments 2 and 4), cryopreservation vessels (Experiment 3) and the addition of an apoptosis inhibitor (Experiment 5). (A)
Spermatogonial stem-cell transplantation (SSCT) outcome was observed via anti-green fluorescence protein (GFP) immunohistochemistry.
Adult mouse GPF+ testicular tissue with (B) and without (C) addition of primary antibody were used as positive and negative controls
respectively. SSCT using freshly isolated testicular cells before cryopreservation (D). SSCT using cells cryopreserved with the optimal
cryopreservation protocol (plus apoptosis inhibitor [AI]) (E). Results in (A) are expressed as means ± SD, for each protocol n = 12 testicular
cell suspensions were treated. *P = 0.0480, **P = 0.0049, ***P < 0.0001 by Kruskal–Wallis multiple comparisons test (Dunn’s post-hoc).
S, sucrose; T, trehalose; DMSO, dimethyl sulfoxide; FCS, fetal calf serum; MSF, multiple-rate controlled slow freezing programme;
SSF, controlled slow freezing rate programme, VF, vitrification.
Table 1 – Absolute number of viable cells in prepubertal mouse testicular cell suspensions after cell isolation, addition of
cryoprotective agent and cryopreservation–thawing or warming under different cryopreservation protocols.a
Experimental group Protocol n Number of viable cells
before cryopreservation
After CPA addition After freeze–thawing
or vitrification–warming
1 MSF 12 3.3x105 ± 1.6x105 3.2x105 ± 1.3x105 1.2x105 ± 1.1x105c
SSF 12 4.2x105 ± 2.6x105 4.7x105 ± 2.9x105 1.7x105 ± 1.3x105c
VF 12 4.2x105 ± 2.5x105 3.8x105 ± 1.7x105 3.3x104 ± 3.8x104c
2 –S 12 3.8x105 ± 9.7x104 2.9x105 ± 1.2x105 1.1x105 ± 8.4x104c
+S 12 3.9x105 ± 9.0x105 3.3x105 ± 1.8x105b 1.2x105 ± 8.0x104c
3 straws 12 4.0x105 ± 2.0x105 3.3x105 ± 1.5x105 1.0x105 ± 5.0x104c
vials 12 4.0x105 ± 2.0x105 2.7x105 ± 2.3x105 2.0x105 ± 1.2x105c
4 –T 12 3.6x105 ± 8.8x104 2.7x105 ± 1.2x105 1.6x105 ± 5.2x104c
+T 12 3.8x105 ± 1.5x105 2.6x105 ± 2.4x105 1.3x105 ± 7.8x104c
5 –AI 12 4.6x105 ± 9.0x104 3.4x105 ± 1.5x105 2.3x105 ± 9.2x104c
+AI 12 4.5x105 ± 1.0x104 3.1x105 ± 2.4x105 2.6x105 ± 8.5x104c
AI, apoptotic inhibitor; CPA, cryoprotective agent; MSF, multiple-rate controlled slow freezing program; S, sucrose; SSF, slow freezing rate programme,
T, trehalose; VF, vitrification.
a For protocol details see Figure 2D.
b P = 0.0047 by Kruskal–Wallis test (compared with the number of cells after isolation).
c P < 0.0001 by Kruskal–Wallis test (compared with the number of cells after cell isolation).
ARTICLE IN PRESS
Please cite this article in press as: Jaime Onofre, Katrien Faes, Prashant Kadam, Elena Vicini, Ans M. M. van Pelt, Ellen Goossens, What is the best protocol to cryopreserve
immature mouse testicular cell suspensions?, Reproductive BioMedicine Online (2018), doi: 10.1016/j.rbmo.2018.04.045
7R E P R O D U C T I V E B I O M E D I C I N E O N L I N E ■ ■ ( 2 0 1 8 ) ■ ■ – ■ ■
Table 2 – Testis with donor-derived spermatogenesis.a,b
Experiment Protocol Average number of
transplanted cells ± SD
Number of testes with donor-derived
spermatogenesis/total number of
transplanted testes
Average testicular
weight at analysis (mg)
TFI (%)c
1 Fresh 1.2x105 ± 8.1x104 4/6d 30.70 ± 8.65 40p
MSF 1.4x105 ± 7.1x104 2/5e 28.30 ± 5.23 3q
SSF 1.0x105 ± 1.2x105 2/5e 28.05 ± 5.73 3q
VF 1.2x105 ± 9.1x104 0/4f 18.56 ± 5.19 0q
2 Fresh 1.4x105 ± 1.6x105 3/4g 31.55 ± 0.78 30r
–S 1.5x105 ± 1.6x105 2/5h 29.72 ± 4.64 2s
+S 1.1x105 ± 1.0x105 2/5h 25.75 ± 3.89 1s
3 Fresh 2.1x105 ± 1.9x105 7/9i 31.89 ± 4.20 35t
straws 2.2x105 ± 1.2x105 4/9j 29.53 ± 4.38 2u
vials 1.2x105 ± 4.2x104 6/8i,k 28.25 ± 6.38 9u
4 Fresh 1.0x105 ± 9.1x104 2/4l 31.50 ± 3.54 37v
–T 1.7x105 ± 1.0x105 2/5l,m 31.15 ± 0.21 5w
+T 1.8x105 ± 7.1x104 1/5n 26.20 ± 6.79 0w
5 Fresh 1.2x105 ± 8.4x104 4/5o 32.33 ± 2.79 33x
–AI 1.4x105 ± 9.2x104 3/5o 30.20 ± 7.22 6y
+AI 1.4x105 ± 9.6x104 3/4o 31.75 ± 1.53 7y
AI, apoptosis inhibitor; MSF, multiple-rate controlled slow freezing program; S, sucrose; SSF, slow freezing rate programme; T, trehalose; VF, vitrification.
a For protocol details see Figure 2D.
b Significance is indicated by the presence of a different superscript within each experimental group.
c Tubular fertility index (TFI) expresses the percentage of tubules containing complete donor-derived spermatogenesis.
After spermatogonial stem-cell transplantation, the number of testis with donor derived spermatogenesis was significantly higher in testis transplanted with
fresh testicular cell suspensions for groups 1–4 respectively: dvse P = 0.0116; dvsf P < 0.0001; gvsh P = 0.0011; ivsj P = 0.0038; lvsn P = 0.0003 by chi-squared test.
Likewise, single (SSF) and multiple (MSF) step controlled freezing as vials and medium without trehalose (–T) presented a significantly higher number of testes
with donor-derived spermatogenesis than their counterparts: evsf P < 0.0001; jvsi,k P = 0.0062; l,mvsn P = 0.0098 by chi-squared test. TFI: pvsq P < 0.0001;
rvss P = 0.0046; tvsu P < 0.0001; vvsw P = 0.0088; xvsy P = 0.0339 by Kruskal–Wallis multiple comparisons test (Dunn’s post-hoc).
B CA
D E F
Figure 4 – Spermatogonial stem cell (SSC) colony formation upon transplantation before and after freeze–thawing. Image of a whole
mount adult green fluorescence protein (GFP+) mouse testis (A) obtained 12 weeks after SSCT with fresh (B) and frozen–thawed cells with
the optimized protocol (C). Donor-derived colonies were defined as distinctive, tapered, green fluorescent areas greater than 0.1 mm
length (D, E). The dynamics of SSC colony formation, cells spreading horizontally (propagation) and vertically (differentiation) along the
seminiferous tubules were observed (F). The scale bar represents 2 mm (A, B, C); 60 µm (D, E); 25 µm (F).
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Discussion
Cryopreservation of isolated TCSs is a prerequisite to SSCT in pa-
tients with a systemic cancer. Unfortunately, testicular tissue
cryopreservation and subsequent grafting presents the risk of rein-
troducing malignant cells and thus cancer relapse (Jahnukainen et al.,
2001). As an alternative for these patients, TCSs generated from stored
testicular tissue can be digested and cultured to allow for SSC iso-
lation and propagation. During the mandatory safety testing that
will be needed before SSCT can be considered, cultured cells will
have to be cryopreserved again (Figure 1). It is still unclear, however,
what cryopreservation technique better protects SSC: tissue
cryopreservation or single cell cryopreservation. Throughout the
cryopreservation process, cells respond differently depending on
whether they are part of a tissue or whether they are in suspension
and cell suspensions have been developed with with the aim to fa-
cilitate cryopreservation. Furthermore, cell heterogeneity in tissues
renders freezing more challenging as a result of the structural limi-
tation of heat and mass transfer. This heterogeneity, however, also
maintains important cell–cell contacts that can safeguard the cells
through cryopreservation and thawing events (Karlsson et al., 1993;
Wyns, 2013). In contrast, cryopreservation of single cell suspen-
sions requires direct exposure to enzymatic and CPA solutions, which
can change the biophysical properties of the cells, resulting in higher
cell sensitivity to cryopreservation events (Brook et al., 2001).
The end goal is to preserve SSCs, for which there is a gap in knowl-
edge and optimal freeze–thawing procedures have yet to be defined.
As such, identifying the key characteristics that influence cell
viability during the freeze–thaw cycle will aid in the preservation of
these valuable cells. Some important criteria have already been iden-
tified; for example, some evidence suggests that SSC are more
resistant to cryopreservation stress compared with differentiated germ
cells (Lee et al., 2013b). Furthermore, the cooling rate during
cryopreservation can be inferred from their cell size and nucleus–
cytoplasm ratio, which in these cells is very similar to hematopoietic
stem cells for which an optimal cooling rate of 1°C/min was already
defined (Berz et al., 2007; Buchanan et al., 2004; Mazur, 1970;
Rodrigues et al., 2008).
In the present study, no difference in RVC was observed between
single and multiple step controlled slow freezing (33 ± 28% and
38 ± 25%, respectively). These results were lower than those re-
ported by Izadyar et al. (2002) and Frederickx et al. (2004), who achieved
50% and 70% cell viability after freezing–thawing, respectively. The
nearly 30% difference could be explained by slight differences in the
protocol. Frederickx et al. (2004) achieved multiple step freezing using
a Planer Kryo 10 biofreezer (Planer products, Gaithsburg, USA),
whereas, for this study, a DB1 biofreezer (Biotronics Ltd, Rotselaar,
Belgium) was used. The efficiency of the DB1 biofreezer may be lower
owing to its single chamber system, allowing the samples to cool by
intermittent soaking of the chamber in LN2 until the desired tem-
perature is reached. The Planer Kryo 10 offers a multi-chamber
system, each with a controlled temperature, which is ideal for mul-
tiple step cryopreservation protocols.
As Frederickx et al. (2004) showed that cooling to −40°C in-
creased cell recovery, but not viability, we adjusted the cooling rate
to −1°C/min, as per Izadyar et al. (2002), reaching a temperature of
−40°C. This reduces the time during which cells remain vulnerable
to ice formation, potentially reducing damage sustained by ice crystal
formation (Mazur, 1984). Furthermore, side-effects such as CPA tox-
icity and cell shrinkage may become less severe as a result of altered
freezing rates (Gilkey and Staehelin, 1986).
The vitrification procedure used in this study was based on the
study by Baert et al. (2013), which was designed for mouse testicu-
lar tissue biopsies. In contrast to controlled freezing, poor cell viability
and survival were achieved. This may be a result of the longer equili-
bration time or incomplete vitrification (crystallization) (Baert et al.,
2012). As SSCs are quite resistant to cryopreservation stress, we hy-
pothesized that the reduced viability after vitrification could be the
result of significant somatic cell death (Kanatsu-Shinohara et al., 2003;
Lee et al., 2013b). The transplantation assay, however, showed that
functional SSCs were not recovered after vitrification.
It has been reported that the addition of the non-permeating CPA
sucrose significantly enhanced survival and viability of bovine sper-
matogonia after thawing, yielding 70% viability (Izadyar et al., 2002).
It was suggested that non-penetrating CPAs, such as sucrose, tre-
halose and dextrane) may offer enhanced membrane stability, helping
the cell to support variances in osmolarity while equilibrating with
the cryoprotective medium. Moreover, non-penetrating CPAs may di-
minish the physical damage encountered during ice-nucleation (Acker
and McGann, 2003; Jain and Roy, 2009; Karlsson et al., 1993; Lee et al.,
2014). Nevertheless, addition of sucrose did not improve post-thaw
Table 3 – Number and length of donor-derived spermatogonial stem-cell colonies in testes transplanted with cryopreserved cells with
the optimal protocol and fresh testicular cell suspensions.a,b
Freshly digested testicular
cell suspensions
Freeze–thawed
(optimized protocol)
Percentage recovery of viable cells (%RVC) 92 ± 4c 63 ± 11
Number of testis with donor-derived spermatogenesis (%) 3/3 (100%) 4/4 (100%)
Number of colonies/testis 8.33 ± 3.06d 3.25 ± 0.96
Number of colonies/105 cells injected 4.08 ± 0.28 2.01 ± 0.93
Number of colonies/testis corrected for transplantation efficiency (12%)f 34.04 ± 2.34e 16.78 ± 7.76
Length of colonies (mm) 3.94 ± 2.47 2.95 ± 0.37
RVC, recovered viable cells.
a Values are mean ± SD.
b t-test was used to assess significant differences.
c P < 0.0001.
d P = 0.0236.
e P = 0.0051.
f Number of colonies corrected for the colonization efficiency of 12% (Nagano et al., 1999).
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cell recovery and viability. Similarly, Lee et al. (2013b) recently showed
that adding trehalose to the cryomedium has a concentration-
dependent effect on mouse SSC recovery and proliferation capacity
after freeze–thawing (Jain and Roy, 2009; Lee et al., 2014). Treha-
lose is a complex disaccharide known to facilitate cellular integrity
as a stress-response factor. Notably, it allows for efficient preser-
vation of mammalian cells (Eroglu et al., 2000; Jain and Roy, 2009).
In the present study, TCSs cryopreserved in the presence of treha-
lose displayed decreased cell viability and very low SSC activity after
SSCT. Taken together, our results strongly suggest that SSC are sen-
sitive to osmotic variations in the cryomedium. Indeed, it has been
reported that improved cell survival stemming from the addition of
sugar molecules is achieved by preculturing cells in cryopreservation
medium with a given molecule (Agca et al., 2005; Mazur and Cole,
1989; Seijo, 2000). Including a 10–15 min incubation time before ini-
tiating cryopreservation would allow the cells to recover from the
osmotic stress caused by the addition of sugars (Izadyar et al., 2002).
As we did not include an equilibration time, our protocol may have
predisposed the testicular cells to osmotic shock, resulting in de-
creased cell recovery. Any further optimization should, therefore,
consider the influence of equilibration times with non-permeating CPAs
on SSC cryopreservation.
Additionally, we investigated the difference in viability
between cryovials and cryostraws, which necessitated a change in
cryopreservation device as our biofreezer does not function with vials.
Alternatively, an isopropyl-container was used, resulting in a signifi-
cantly improved cell survival compared with cryostraws cooled in a
biofreezer (52% ± 20 versus 33% ± 20 RVC), which may be due to a
reduction in mechanical damage to the cells (Saragusty et al., 2009).
Indeed, during freezing, extracellular ice nucleation and expansion
increases the intra-vessel pressure, which combined with extracel-
lular ice nucleation, may apply pressure to the cells to the unfrozen
part of the medium causing cell crushing by a ‘pack effect’. As a result,
the larger the surface area with which cells are in contact in the
medium, the greater the damage (Saragusty et al., 2009). Storing 200
µl in a 1.8 ml vial permits a higher surface-area-to-volume ratio com-
pared with storing 200 µl in a 0.5 ml cryostraw (Gilkey and Staehelin,
1986; Saragusty et al., 2009). The pressure created by ice crystals might
thus be released in the empty vessel space, diminishing the ‘pack
effect’ and resulting in an increase in cell viability and recovery. It
would be of interest to use vials in combination with a programmed
controlled freezing rate to further increase viability.
Finally, the mitochondrial caspase 9 apoptotic pathway is thought
to be responsible for cryopreservation-induced delayed-onset cell
death (Bissoyi et al., 2014). The apoptotic inhibitor Z-VAD-(OMe)-
FMK is the most suitable candidate owing to its broad spectrum
inhibitory proprieties against caspases and its irreversible effect on
cells (Bissoyi et al., 2014; Ha et al., 2016; Peter and Linde-Forsberg,
2003). A few studies on mouse spermatogonia frozen with a
cryomedium, including an anti-apoptotic factor, have been pub-
lished (Ha et al., 2016; Lee et al., 2013a). In our study, Z-VAD-(OMe)-
FMK led to significantly higher recovery of viable cells (61 ± 18%).
Nevertheless, the number of viable cells recovered after thawing can
still be improved. Additional attention could be given to the thawing
process, which is as important as freezing. In this study, samples were
thawed in a 37°C water bath, which is considered a standard proce-
dure. Controlled thawing is an unexplored, yet promising alternative
that deserves to be studied (Gurina et al., 2015). Also, further study
of vitrification is warranted as it is a fast and easy way to cryopreserve
cell samples.
Furthermore, it has been shown that cell viability does not cor-
relate with the functional capacity of the SSCs (Frederickx et al., 2004).
The SSCT assay, as we used in this study, is the gold standard to verify
and quantify the presence, proliferation and differentiation capacity
of donor SSCs after freeze–thawing procedures. Consideration,
however, must be given to primary testicular cell propagation culture
in future studies, as it is a fundamental step for the future clinical
application of the SSCT technique (Sadri-Ardekani et al., 2009).
Although immature mouse SSCs can be cryopreserved and retain
spermatogenic function upon freeze–thawing, the present results may
not be easily extrapolated to humans owing to the different struc-
ture and biology of the human testis (Kanatsu-Shinohara et al., 2003).
Therefore, additional research will be necessary to develop a suit-
able clinical grade procedure with xenofree cryopreservation media
(Hermann et al., 2012; Karlsson and Toner, 1996; Tournaye et al., 2004).
In conclusion, using a controlled slow-freezing method includ-
ing 1.5M DMSO, 10% FCS and 60 µM of Z-VAD-(OMe)-FMK in DMEM
as cryoprotection medium in vials leads to the highest recovery of
viable cells (61%) currently reported. Importantly, the superiority of
the proposed cryopreservation protocol was confirmed by SSCT. When
comparing the number of donor-derived stem cell colonies after trans-
plantation of cryopreserved and fresh TCSs, a recovery of 49% of the
original SSCs could be shown (Table 3). These cryopreservation con-
ditions are relevant for the eventual translation of this cryopreservation
protocol to human TCSs, in the hope of supporting a future clinical
application.
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